BMC Global and Public Health

BMC Global and Public Health is an open access journal from BioMed Central, part of Springer Nature, which published its first articles in 2023 and covers global and public health research, policy and practice, with a 2025 Journal Impact Factor of 5.1.《BMC 全球与公共卫生》（BMC Global and Public Health）是（BioMed Central，属 Springer Nature）出版的全开放获取期刊，2023 年发表首批文章，覆盖全球与公共卫生的研究、政策与实践，2025 年期刊影响因子为 5.1。

Scope

• Stated interests run from disease epidemiology and population health to health policy, including surveillance and modelling of both communicable and non-communicable disease.公开的收稿范围从疾病流行病学、人群健康延伸到卫生政策，包括传染病与非传染病的监测与建模。
• Health equity is presented as the core of the journal mission, with explicit attention to populations under-represented in health research and in scientific publishing.健康公平被列为核心使命，明确关注在健康研究与科学出版中长期代表性不足的人群。
• Environmental and occupational health forms another pillar, covering climate change, air pollution, occupational noise and One Health approaches to antimicrobial resistance.环境与职业健康是另一支柱，涵盖气候变化、空气污染、职业噪声，以及针对抗微生物药物耐药性的同一健康路径。
• Health systems, health economics and implementation science are in scope, framed around informing policy-making and service delivery in low-income and middle-income settings.卫生体系、卫生经济学与实施科学亦在范围内，重点是为中低收入环境的政策制定与服务提供提供依据。
• Reproductive, maternal, newborn and child health, sexual and reproductive health services and adolescent health all fall within the remit.生殖、孕产、新生儿与儿童健康，性与生殖健康服务，以及青少年健康，均属收稿范围。
• Mental health, oral health and the social determinants of health are listed alongside methodological interests in clinical trials, statistical methods and evidence synthesis.精神健康、口腔健康与健康社会决定因素亦被列入，并与临床试验、统计方法、证据合成等方法学方向并列。

History

• The title was built as a selective flagship for BMC, the open access imprint of Springer Nature, and was launched by Gerrit John-Schuster, who took charge of the project in 2022.本刊是（Springer Nature）旗下开放获取品牌（BMC）的选择性旗舰刊，由（Gerrit John-Schuster）于 2022 年接手筹办并创办。
• Its first articles appeared on 31 July 2023, opening volume 1 with the editor introduction plus research on cervical cancer screening in Rwanda and on child marriage in sub-Saharan Africa.首批文章于 2023 年 7 月 31 日上线，第 1 卷以主编导言以及卢旺达宫颈癌筛查、撒哈拉以南非洲童婚两项研究开篇。
• It sits beside BMC Public Health, a BMC Series journal running for more than two decades, but departs from that inclusive outlet by selecting only work judged a significant advance.本刊与已出版二十余年的（BMC Series）刊物（BMC Public Health）并列，但与该刊广纳可靠研究的定位不同，只选用被判定为重要进展的稿件。
• Articles carry continuous article numbers instead of issue pagination, and volume 4 in 2026 has already passed article number 100.文章采用连续文章编号而非按期分页，2026 年第 4 卷的文章编号已超过 100。
• Publication is fully open access from the outset, with an article processing charge of 1950 pounds, 2690 US dollars or 2290 euros and a country-tiered pricing pilot that replaced low-income waivers.自创刊起即为全开放获取，文章处理费为 1950 英镑、2690 美元或 2290 欧元，并实行按国别分级的定价试点，取代原有的低收入国家豁免。
• The 2025 Journal Impact Factor is 5.1, equal to the five-year figure, ranking the journal 51 of 443 in public, environmental and occupational health, while the median submission reaches a first decision in two days.2025 年期刊影响因子为 5.1，与五年影响因子持平，在公共卫生、环境与职业健康类别位列 51/443，稿件中位首次决定时间为两天。

Editors

• Gerrit John-Schuster, who holds a master degree in environmental science and a PhD in cell and molecular biology, is Chief Editor and works from the Springer Nature office in New York.（Gerrit John-Schuster）拥有环境科学硕士与细胞及分子生物学博士学位，任主编，在（Springer Nature）纽约办公室工作。
• He joined BMC in 2019 as an editor of Genome Medicine, handling public health, epidemiology, infectious and non-communicable disease, immunology and clinical diagnostics before founding this title.他于 2019 年加入（BMC）任（Genome Medicine）编辑，负责公共卫生、流行病学、传染性与非传染性疾病、免疫学与临床诊断，其后创办本刊。
• Two Senior Editors share the handling load: Ben Cranfield in London, an epidemiologist trained at University College London who covers cancer, health equity and health technology, and Gen Li in Shanghai, a psychologist covering mental health, trials and statistical methods.两位高级编辑分担稿件处理：（Ben Cranfield）驻伦敦，在（University College London）接受流行病学训练，负责肿瘤、健康公平与卫生技术；（Gen Li）驻上海，心理学背景，负责精神健康、临床试验与统计方法。
• The editorial board lists about sixty members across more than twenty-five countries, with the United States and the United Kingdom the largest contingents, and every entry names an institutional affiliation and declared specialisms.编委会公布约六十位成员，分布于二十五个以上国家，以美国与英国人数最多，每位成员均标注所属机构与自述专长领域。
• Review is transparent towards readers: at least two external experts assess each manuscript, and accepted papers appear with the reviewer reports under a CC BY 4.0 licence, although reviewers are not named.评审对读者透明：每篇稿件至少由两位外部专家评估，录用文章随文发布审稿报告并以（CC BY 4.0）许可开放，但不披露审稿人姓名。
• Research, systematic reviews and registered reports carry the research content, while comments, reviews, perspectives, forums and matters arising are largely commissioned to frame debate around published findings.研究论文、系统综述与注册报告构成研究类内容，评论、综述、视角、论坛与商榷文章多为约稿，用以围绕已发表结果组织讨论。